Page 2 - Best KRAS, NRAS,BRAF mutation testing doctors: TOP 41 doctors

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

The doctor is a Medical Oncologist and Radiotherapist with 33 years of experience, specializing in Oncology and Radiotherapy. They graduated from Hadassah University Hospital in Jerusalem, Israel, and hold qualifications in both Oncology and Radiotherapy.

Currently serving as the Head of the Gastrointestinal Cancer Center, the doctor is also a Senior Physician in the Oncology Department at Hadassah University Hospital. They have completed board exams in Oncology and Radiotherapy, and are a member of several professional societies, including the Israel Society of Clinical Oncology and the Israel Cancer Association.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

The doctor is a leading expert in the treatment of non-Hodgkin lymphoma and specializes in blood disorder treatment. With over 30 years of practice, the doctor heads the Hematology sector at Nordwest Clinic, focusing on advanced hematological care and research.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

The doctor completed specialization training in Radiation Oncology at Marmara University Faculty of Medicine from 2012 to 2016. Prior to this, the doctor completed an undergraduate degree in Medicine, taught in English, at the same institution from 2004 to 2011. The doctor has a strong foundation in medical education, beginning with high school education at Sixteen Numbered Shirvan School in Azerbaijan from 1998 to 2004.

The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.

The doctor received Surgical Oncology training at Tata Memorial Hospital, Mumbai, and completed MRCS at the Royal College of Surgeons, Edinburgh. Starting practice in 2000, the doctor founded Curie Manavata Cancer Centre in 2007. With 19 years of experience, the doctor has performed over 50,000 cancer surgeries and participated in more than 200 clinical trials. The doctor is a published author with numerous international and national publications. Specializing in Breast and Thoracic Surgical Oncology, the doctor is a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at MUHS.

The doctor completed an MD in Internal Medicine at Shyam Shah Medical College and held a Senior Residency in the same department. Following this, the doctor served as Registrar in Medical Oncology at Jawaharlal Nehru Cancer Hospital. The doctor completed DNB training in Medical Oncology at Indraprastha Apollo Hospital.

During the Senior Residency, the doctor lectured at the International Winter School of Oncology at AIIMS and presented research on Stomach Cancer at the Gastrointestinal Cancer Symposium by the American Society of Clinical Oncology. The doctor specializes in the molecular basis of cancer and targeted therapies.

The doctor completed an MBBS from MIMER, Pune, and an MS from GMC Panaji. Further training included a two-year fellowship in Surgical Oncology at Tata Medical Centre, Kolkata, focusing on Gastrointestinal Cancer. At Tata Medical Center, the doctor served as a Co-principal Investigator in multiple original research projects. Following this, the doctor worked as an Assistant Professor at the State Cancer Institute and Government Cancer Hospital, Aurangabad. With over 10 years of experience, the doctor has successfully performed more than 10,000 major surgeries and has published multiple National and International papers. Specializes in Minimal Invasive Cancer Surgeries.

The doctor is an accomplished educator and researcher in the field of oncology, with extensive teaching experience at USP CEU. The doctor has taught a wide array of subjects including General Medical Pathology, Oral and Maxillofacial Oncology, and Bioethics. As a tutor for medical students and external rotants, the doctor has contributed significantly to the training of future healthcare professionals.

Additionally, the doctor holds the position of Director of postgraduate research in clinical and applied oncology at HM CIOCC USP CEU and is responsible for postgraduate master practices. The doctor has also completed advanced courses at MD Anderson Cancer Center.

The doctor graduated from Uludağ University Medical College with a Diploma of Medicine in 1983 and completed a residency in Radiation Oncology at the Center of Oncology & Nuclear Medicine in Istanbul in 1990. A post-doctoral fellowship in Thermoradiotherapy was completed at Thomas Jefferson University from 1990 to 1994. The doctor served as Professor and Chairman of the Department of Radiation Oncology at Uludağ University Medical College from 1994 to 2005 and was the Faculty Accreditation Coordinator from 2001 to 2004.

From 2004 to 2017, the doctor was a Professor and Director of the Department of Radiation Oncology at Anadolu Medical Center, also serving as Coordinator of Oncological Sciences from 2011 to 2017. Currently, the doctor is the Director of Oncological Sciences at Medicana Bursa Hospital, a position held since 2018.

The doctor is a highly skilled oncologist specializing in the treatment of various cancer types, including solid tumors, pediatric tumors, and hematological malignancies. She is proficient in both conservative and surgical treatments, such as the Whipple procedure.

She completed her MBBS at Lady Hardinge Medical College and MD in internal medicine from Maulana Azad Medical College. She further pursued DM Medical Oncology at Tata Memorial Hospital, where she also served as a consultant.

She is affiliated with international and national oncological societies and has expertise in lung, breast, gynecological, and genitourinary cancers, with a keen interest in immunotherapy and metronomic therapy.